Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events

被引:43
|
作者
Burn, Edward [1 ]
Nghiem, Son [1 ]
Jan, Stephen [2 ]
Redfern, Julie [2 ]
Rodgers, Anthony [2 ]
Thiagalingam, Aravinda [3 ,4 ]
Graves, Nicholas [1 ]
Chow, Clara K. [2 ,3 ,4 ]
机构
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia
[3] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia
[4] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; RISK-FACTOR; LIFE-STYLE; SMOKING; HEALTH; MODEL; INTERVENTIONS; INDIVIDUALS; UNCERTAINTY; STROKE;
D O I
10.1136/heartjnl-2016-310195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To estimate the cost-effectiveness of Tobacco, Exercise and Diet Messages (TEXT ME), a text message-based intervention that provides advice, motivation, information and support to improve health-related behaviours. Methods A lifetime Markov model was used to estimate major vascular events (myocardial infarctions and strokes) avoided, quality-adjusted life years (QALYs) gained, costs to the health system and the incremental cost per QALY gained. The model was informed by data from a randomised controlled trial of TEXT ME, with evidence from systematic reviews and meta-analyses used to estimate the effects of changes in risk factors on the risk of major vascular events. Expected costs and health outcomes were estimated with uncertainty surrounding these characterised using probabilistic sensitivity analysis and a number of scenario analyses. Results For a target population of 50 000 patients with documented coronary heart disease, the intervention is expected to lead to 563 fewer myocardial infarctions, 361 fewer strokes and 1143 additional QALYs. TEXT ME is expected to lead to an overall saving of $ 10.56 million for the health system over the patients' lifetimes. The intervention can therefore be considered cost-saving and health-improving. Neither parameter nor structural uncertainty had a significant impact on the conclusion that TEXT ME is cost-effective. Conclusions The provision of TEXT ME is predicted to lead to better health outcomes and an overall saving in costs for the health system.
引用
收藏
页码:923 / U57
页数:8
相关论文
共 50 条
  • [21] Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population
    Tonkin, Andrew M.
    Boyden, Andrew N.
    Colagiuri, Stephen
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (06) : 300 - 302
  • [22] Re: Medical therapy for preventing recurrent endometriosis after conservative surgery: a cost-effectiveness analysis: Cost-effectiveness in recurrent endometriosis prevention
    Pandey, Saumya
    Tyagi, Rajul
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (04) : 503 - 504
  • [23] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Tolla, Mieraf Taddesse
    Norheim, Ole Frithjof
    Memirie, Solomon Tessema
    Abdisa, Senbeta Guteta
    Ababulgu, Awel
    Jerene, Degu
    Bertram, Melanie
    Strand, Kirsten
    Verguet, Stephane
    Johansson, Kjell Arne
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2016, 14
  • [24] COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION
    Earnshaw, S.
    Pignone, M.
    Fendrick, A. M.
    Scheiman, J. M.
    McDade, C.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A166
  • [26] Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
    Kohli-Lynch, Ciaran N.
    Moran, Andrew E.
    Kazi, Dhruv S.
    Bibbins-Domingo, Kirsten
    Jordan, Neil
    French, Dustin
    Zhang, Yiyi
    Wang, Thomas J.
    Bellows, Brandon K.
    JAMA CARDIOLOGY, 2025, 10 (03) : 224 - 233
  • [27] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Mieraf Taddesse Tolla
    Ole Frithjof Norheim
    Solomon Tessema Memirie
    Senbeta Guteta Abdisa
    Awel Ababulgu
    Degu Jerene
    Melanie Bertram
    Kirsten Strand
    Stéphane Verguet
    Kjell Arne Johansson
    Cost Effectiveness and Resource Allocation, 14
  • [28] THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR (CV) EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) IN TURKEY
    Parali, E.
    Deger, C.
    Ozdemir, O.
    Afsar, N.
    Aykut Aka, S.
    Degertekin, M.
    Ergene, O.
    Ongen, Z.
    Ozdemir, M.
    Sumer, F.
    Yilmaz, Z. S.
    Ozel, M. O.
    VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [29] Prevention of cardiovascular diseases in Nairobi slums: a cost-effectiveness study
    van de Vijver, Steven
    Oti, Samuel
    Gomez, Gabriela B.
    Agyemang, Charles
    Lange, Joep
    Kyobutungi, Catherine
    LANCET, 2014, 384 : S12 - S12
  • [30] Pravastatin cost-effectiveness for primary prevention of cardiovascular disease in the US
    Hay, JW
    Yuan, Y
    Ford, I
    McGuire, A
    Shepherd, J
    CIRCULATION, 1997, 96 (08) : 1017 - 1017